2977251-02-6
Chemical Structure
HCVcc-IN-2
- CAS No.: 2977251-02-6
- Formula:C32H29BrN2O10S3
- Molecular Weight:777.68
IUPAC Name: (2R,3R,4S,5R,6S)-2-(acetoxymethyl)-6-((4-amino-3-(benzo[d]thiazol-2-yl)-5-(4-bromobenzoyl)thiophen-2-yl)thio)tetrahydro-2H-pyran-3,4,5-triyl triacetate
InChIKey: CYIHWQMUPAKXIU-GERGHJGDSA-N
SMILES: O=C(C1=C(N)C(C2=NC3=CC=CC=C3S2)=C(S[C@H]4[C@H](OC(C)=O)[C@@H](OC(C)=O)[C@@](OC(C)=O)([H])[C@@H](COC(C)=O)O4)S1)C5=CC=C(Br)C=C5
Biological Activity: HCVcc-IN-2 is a benzothiazole-2-thiophene S-glycoside derivative with antitumor and antiviral activity. HCVcc-IN-2 has high inhibition against the three cell line from CNS cancer (SF-539 and SNB-75), colon cancer (HCT-116), and renal cancer (A498)[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
HCVcc-IN-2 | HCVcc-IN-2 is a benzothiazole-2-thiophene S-glycoside derivative with antitumor and antiviral activity. HCVcc-IN-2 has high inhibition against the three cell line from CNS cancer (SF-539 and SNB-75), colon cancer (HCT-116), and renal cancer (A498). | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
